Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic Valve Implantation "POPular-TAVI"

Recruiting

Phase 4 Results N/A

Eligibility Criteria

Inclusion Criteria

- Cohort A
1. Patient has provided written informed consent.
- Cohort B
1. Need for long-term oral anticoagulation;
2. Patient has provided written informed consent.

Exclusion Criteria

- Cohort A
1. Need for long-term oral anticoagulation;
2. Drug-eluting stent implantation within 3 months prior to TAVI procedure;
3. Bare-metal stent implantation within 1 month prior to TAVI procedure;
4. Allergy or intolerance to aspirin or clopidogrel.
- Cohort B
1. Drug-eluting stent implantation within 3 months prior to TAVI procedure;
2. Bare-metal stent implantation within 1 month prior to TAVI procedure;
3. Use of non-vitamin K oral anticoagulation (NOAC);
4. Allergy or intolerance to OAC or clopidogrel.